Replies to post #4613 on BioSante Pharmaceuticals, Inc. (BPAX)

[ZNSTATED]

Got to admit I'd like to hear something positive from the company in a PR especially after those lawyer PR s last week

[MR 1955 DOUBLE DIE]

excellent !! agreed....

[Just the facts maam]

It appears that the partnership between Jazz and Azur could create some revenue for BPAX. As they focus on expanding the market for Elestrin.

According to the Jazz and Azur Partnership

• Significant growth opportunity driven by Elestrin , a topical gel ERT therapy
• Patents through 2022
• Revamped Elestrin promotion model in 2010 leveraging 51 sales representatives

If you look at page 12 of the slide presentation you will see that Elestrin is tracking in the right direction for future revenue growth.